FTXH ETF (First Trust Nasdaq Pharmaceuticals ETF) is managed by First Trust Portfolios (US) with $29.4M in net assets. FTXH expense ratio is 0.60%, holding 51 positions across sectors including Health Care, Unknown, Consumer Staples. Inception date: 2016-09-20.

FTXH performance shows a YTD return of 7.54%. The 1-year return is 27.73% and the 5-year return is 8.13%. FTXH dividend yield stands at 1.30%, paid quarterly.

FTXH top holdings include Merck & Company Inc (8.1%), Johnson & Johnson (7.8%), Bristol-Myer Sq (7.4%), Pfizer, Inc. (6.3%), Abbvie Inc (6.1%). View all FTXH holdings, sector breakdown, or dividend history.

FTXH can be compared against other funds using the overlap calculator or side-by-side comparison tool. FTXH alternatives are available via the screener, along with tax-loss harvesting opportunities.